Project Number EUJPND-WellcomeTrust-Mahley-2190 Agency/Funding Organization The Wellcome Trust Funding Year 2016 View Full Project Details for Apolipoprotein E4 as a Therapeutic Target for Alzheimer's Disease: Identification of Small-Molecule Structure Correctors That Prevent Apolipoprotein E4 Associated Neuropathology Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator Mahley, Robert Principal Investigator First Name Robert Principal Investigator Last Name Mahley Awardee Organization Gladstone Institutes Contact PI Country United Kingdom Project Detail FY Overall Cost $410,760 Funding Organization Agency/Funding Organization The Wellcome Trust Funding Organization Country United Kingdom Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
